MC-90984EV FDA EVA LAVENDER MD-17152 ROYAL BLUE Shipment Notification - under "Material Header" MSDS - labeled as the "Product Number" (in Section 1)

CVA BLUE M2693C BLUE TINT FDA Shipment Notification - under "Material Header" MSDS - labeled as the "Product Number" (in Section 1)

MC-17461PE LIGHT BLUE FDA BLUE Shipment Notification - under "Material Header" MSDS - labeled as the "Product Number" (in Section 1)

023613CMB YELLOW - FDA BLUE Shipment Notification - under "Material Header" MSDS - labeled as the "Product Number" (in Section 1)

Get Help Now +1-866-737-2066 Supplied a non-phthalate plastisol solution in specified colors to meet all performance requirements Liquid at room temperature, these customized resins can also be toll blended for any application

LIQUID-KELLY GREEN BLUE RPET TONER LIQUID UV DESIGN

Slide 1 PolyOne Corporation Page 1 PolyOne Investor Presentation Credit Suisse Basic Materials Conference June 25-26, 2014 PolyOne Corporation Page 2 Forward-Looking Statements  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. S&P 500 All time high of $42.47 June 6th, 2014 PolyOne Corporation Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Healthcare Consumer Packaging and Additive Technology Transportation Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.4 million shares in Q1 2014 Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment PolyOne Corporation Page 16 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? Platform operating income mix percentage 2005Y* 2008Y* 2010Y* 2013Y 2014 Q1 Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 49.7 $ 57.2 $ 18.3 Global Color, Additives and Inks 4.3 28.1 37.7 104.0 30.4 Designed Structures and Solutions - - - 33.4 11.2 Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 59.9 Performance Products and Solutions 75.7 31.3 54.0 56.0 16.0 Distribution 19.5 28.1 42.0 63.3 17.2 SunBelt Joint venture 91.9 28.6 18.9 - - Corporate (51.5) (425.1) (27.7) (82.4) (36.7) Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 56.4 Less: Corporate operating expense 51.5 425.1 27.7 82.4 36.7 Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 93.1 Specialty platform operating mix percentage 2% 34% 43% 62% 64% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.

MAGIQ FIBER COLORANTS - LIQUID Part of our MagiQ Fiber Colorants & Additives brand, and manufactured under ColorMatrix™ Fiber Colorant Solutions, this breakthrough technology combines advanced liquid color formulations with state-of-the-art, high-pressure metering equipment to enable late-stage injection of liquid color for spun-dyed polyester melt. It works by injecting liquid color at high pressure into the polyester melt-flow between the end of the extruder, or melt-pipe, and the spin head. A broad spectrum palette of liquid colorants (40%–80% pigment or dye loading) is available for custom colors and a variety of pigment and dye preparations, including additives and color and additive blends, available on request.

LIQUID ANTIMICROBIAL OB TRACER V2 LIQUID ANTIMICROBIAL OB TRACER V3 D28081 BLUE WHITE PSC

HEALTHCARE DEVICE MANUFACTURER W E B K N E E B R A C E • Good bonding to polypropylene (PP) • Flexible and soft-touch feel • Skin contact, general FDA compliance • Good tensile strength and resilience • Excellent colorability • Offered material that passed the required FDA regulations • Provided high elasticity memory and ultra soft tactile finish to meet the comfort and pleasant surface feeling requirements • Delivered TPE with easy and stable processing and colorability DynaflexTM Thermoplastics Elastomer KEY REQUIREMENTS WHY AVIENT?